Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 4,167 | 2,534 | 2,505 | 2,309 | 1,872 |
| Operating Income | -4,167 | -2,534 | -2,505 | -2,309 | -1,872 |
| Other Income | 164 | 163 | 113 | 143 | 103 |
| Pre-tax Income | -4,003 | -2,371 | -2,392 | -2,166 | -1,769 |
| Net Income Continuous | -4,003 | -2,371 | -2,392 | -2,166 | -1,769 |
| Net Income | $-4,003 | $-2,371 | $-2,392 | $-2,166 | $-1,769 |
| EPS Basic Total Ops | -0.34 | -0.15 | -0.44 | -0.45 | -0.41 |
| EPS Basic Continuous Ops | -0.34 | -0.15 | -0.44 | -0.45 | -0.41 |
| EPS Diluted Total Ops | -0.34 | -0.15 | -0.44 | -0.45 | -0.41 |
| EPS Diluted Continuous Ops | -0.34 | -0.15 | -0.44 | -0.45 | -0.41 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.15 | -0.44 | -0.45 | -0.41 |
| EBITDA(a) | $-4,166 | $-2,533 | $-2,505 | $-2,309 | $-1,872 |